First Trust Direct Indexing L.P. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 261 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
First Trust Direct Indexing L.P. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$312,000
+11.4%
9,209
-4.8%
0.05%
+17.9%
Q2 2022$280,000
-2.8%
9,673
+8.6%
0.04%
+11.4%
Q1 2022$288,000
+20.5%
8,903
+8.8%
0.04%
+12.9%
Q4 2021$239,000
+9.6%
8,1830.0%0.03%0.0%
Q3 2021$218,000
+27.5%
8,183
+20.7%
0.03%
-32.6%
Q4 2020$171,0006,7820.05%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders